CAS NO: | 2093536-13-9 |
包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
1 g | 电议 |
生物活性 | Thalidomide-NH-C6-NH-Boc is a synthesizedE3 ligase ligand-linker conjugatethat incorporates the Thalidomide basedcereblonligand and a linker used for MI-389 (compound 22) synthesis. MI-389 is a potent phthalimidePROTACdegrader based on the multi-targeted receptor tyrosine kinase inhibitor sunitinib (HY-10255A)[1]. | ||||||||||||||||
IC50& Target[1] |
| ||||||||||||||||
体外研究 (In Vitro) | MI-389 (0-1 μM; 72 hours) decreases cell growth with an EC50value of 21.3 nM, which is comparable to the cellular potency of sunitinib (EC50=17.3 nM)[1].MI-389 (0-500 nM; 72 hours) leads to GSPT1 destabilization fastly as a dosepdependent manner. It shows a complete GSPT1 depletion at 100 nM[1]. Cell Viability Assay[1]
Western Blot Analysis[1]
| ||||||||||||||||
分子量 | 472.53 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C24H32N4O6 | ||||||||||||||||
CAS 号 | 2093536-13-9 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 100 mg/mL(211.63 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|